TABLE 4.

Impact of PROCOMIDA treatment groups compared with control on growth of Guatemalan children¹

	FFR + CSB	RFR + CSB	NFR + CSB	FFR + LNS	FFR + MNP
	(n = 576)	(n = 575)	(n = 542)	(n = 550)	(n = 587)
Stunted (length-for-age z score <−2)
1 mo	−5.05*	−4.06*	−1.38	−1.39	−3.82*
4 mo	−2.03	−2.18	−0.63	−2.52	−3.21
6 mo	−4.36	−2.68	0.02	−1.28	−4.20
9 mo	−5.60*	0.87	1.95	−0.63	−5.83*
12 mo	−6.56*	0.83	−3.42	−2.28	−5.81*
18 mo	−6.15	1.69	−3.04	−3.74	−3.20
24 mo	−11.10**	−1.42	−4.25	−3.00	−6.54*
Length-for-age z score
1 mo	0.13 ± 0.07*	0.08 ± 0.06	−0.03 ± 0.07	−0.01 ± 0.08	0.03 ± 0.06
4 mo	0.08 ± 0.07	0.02 ± 0.06	0.01 ± 0.07	−0.01 ± 0.07	0.06 ± 0.06
6 mo	0.05 ± 0.07	0.01 ± 0.07	−0.03 ± 0.07	−0.04 ± 0.07	0.05 ± 0.06
9 mo	0.03 ± 0.07	−0.06 ± 0.07	−0.05 ± 0.07	−0.07 ± 0.07	0.03 ± 0.07
12 mo	0.09 ± 0.07	−0.07 ± 0.08	−0.00 ± 0.08	−0.05 ± 0.07	0.06 ± 0.07
18 mo	0.11 ± 0.07	−0.05 ± 0.07	0.01 ± 0.08	−0.03 ± 0.07	0.04 ± 0.07
24 mo	0.19 ± 0.08*	−0.01 ± 0.08	0.06 ± 0.08	−0.01 ± 0.07	0.11 ± 0.07
Length-for-age difference
1 mo	0.24 ± 0.14*	0.12 ± 0.13	−0.08 ± 0.15	−0.03 ± 0.16	0.05 ± 0.11
4 mo	0.17 ± 0.15	0.03 ± 0.14	0.01 ± 0.15	−0.02 ± 0.15	0.12 ± 0.13
6 mo	0.11 ± 0.16	0.00 ± 0.15	−0.07 ± 0.15	−0.09 ± 0.15	0.10 ± 0.14
9 mo	0.06 ± 0.17	−0.15 ± 0.16	−0.13 ± 0.18	−0.18 ± 0.16	0.06 ± 0.16
12 mo	0.23 ± 0.17	−0.16 ± 0.20	−0.01 ± 0.19	−0.14 ± 0.18	0.15 ± 0.18
18 mo	0.32 ± 0.21	−0.13 ± 0.21	0.03 ± 0.22	−0.08 ± 0.19	0.13 ± 0.19
24 mo	0.59 ± 0.24*	−0.02 ± 0.24	0.21 ± 0.26	−0.04 ± 0.22	0.38 ± 0.22*

¹Values are coefficients ± SEMs or pp from linear mixed model, test of simple effects comparing each treatment group with control (n = 574), *P < 0.05, ** P < 0.01. CSB, corn-soy blend; FFR, full family ration; LNS, lipid-based nutrient supplement; MNP, micronutrient powder; NFR, no family ration; pp, percentage point; RFR, reduced family ration.